StockData
uniQure N.V. logo

uniQure N.V. (QURE) stock

QURENasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 4, 2026Score 4/30224% above fair value
$20.30−0.48 (-2.31%)

Close on Nov 18, 2026Market cap $1.41BP/E –Yield –

uniQure price to sales ratio

The price-to-sales ratio is market cap divided by revenue over the trailing twelve months.

uniQure's price to sales ratio was 91.3× on Nov 11, 2026, against 108.6× a year earlier. Over the last 5 years it ranged from 1.3× to 259.0×, with a median of 15.7×.

Price to Sales Ratio at the end of each year

PeriodPeriod endValueChange (pts)
2026Nov 11, 202691.3×−3.2
2025Dec 31, 202594.4×+64.3
2024Dec 31, 202430.1×+27.2
2023Dec 29, 20232.9×−14.4
2022Dec 30, 202217.3×+15.4
2021Dec 31, 20211.9×−263.6
2020Dec 31, 2020265.5×−233.4
2019Dec 31, 2019498.9×+411.3
2018Dec 31, 201887.6×+62.1
2017Dec 29, 201725.6×+12.7
2016Dec 30, 201612.9×−33.2
2015Dec 31, 201546.1×–

More uniQure figures

See a number that looks wrong?